1. Studies on prostatic cancer. I: The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;Cancer Res.,1941
2. Prostate carcinoma tumor size in rats decreases after administration of antagonists of luteinizing hormone-releasing hormone;Redding;Proc. Natl. Acad. Sci.,1982
3. Endocrine and clinical evaluation of 107 patients with advanced prostatic carcinoma under long-term pernasal buserelin or intramuscular decapeptyl depot treatment;Jacobi;Amer. J. Clin. Oncol.,1988
4. Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide);Kuhn;New Engl. J. Med.,1989
5. A review of the Hammersmith Hospital, St. Bartholomew’s Hospital and Institute of Urology studies of buserelin in advanced prostatic cancer;Waxman;Amer. J. Clin. Oncol.,1988